» Articles » PMID: 30576312

Metabolomics and 16S RRNA Sequencing of Human Colorectal Cancers and Adjacent Mucosa

Overview
Journal PLoS One
Date 2018 Dec 22
PMID 30576312
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is ranked the third most common cancer in human worldwide. However, the exact mechanisms of CRC are not well established. Furthermore, there may be differences between mechanisms of CRC in the Asian and in the Western populations. In the present study, we utilized a liquid chromatography-mass spectrometry (LC-MS) metabolomic approach supported by the 16S rRNA next-generation sequencing to investigate the functional and taxonomical differences between paired tumor and unaffected (normal) surgical biopsy tissues from 17 Malaysian patients. Metabolomic differences associated with steroid biosynthesis, terpenoid biosynthesis and bile metabolism could be attributed to microbiome differences between normal and tumor sites. The relative abundances of Anaerotruncus, Intestinimonas and Oscillibacter displayed significant relationships with both steroid biosynthesis and terpenoid and triterpenoid biosynthesis pathways. Metabolites involved in serotonergic synapse/ tryptophan metabolism (Serotonin and 5-Hydroxy-3-indoleacetic acid [5-HIAA]) were only detected in normal tissue samples. On the other hand, S-Adenosyl-L-homocysteine (SAH), a metabolite involves in methionine metabolism and methylation, was frequently increased in tumor relative to normal tissues. In conclusion, this study suggests that local microbiome dysbiosis may contribute to functional changes at the cancer sites. Results from the current study also contributed to the list of metabolites that are found to differ between normal and tumor sites in CRC and supported our quest for understanding the mechanisms of carcinogenesis.

Citing Articles

Combined tumor-associated microbiome and immune gene expression profiling predict response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer.

Roesel R, Strati F, Basso C, Epistolio S, Spina P, Djordjevic J Oncoimmunology. 2025; 14(1):2465015.

PMID: 39992705 PMC: 11853554. DOI: 10.1080/2162402X.2025.2465015.


Changes in Intestinal Microbiota and Their Relationship With Patient Characteristics in Colorectal Cancer.

Zhao L, Fang Y, Zhang J, Wei C, Ji H, Zhao J Clin Med Insights Oncol. 2024; 18:11795549241307632.

PMID: 39734513 PMC: 11672582. DOI: 10.1177/11795549241307632.


New Insights into Mucosa-Associated Microbiota in Paired Tumor and Non-Tumor Adjacent Mucosal Tissues in Colorectal Cancer Patients.

Gonzalez A, Fullaondo A, Navarro D, Rodriguez J, Tirnauca C, Odriozola A Cancers (Basel). 2024; 16(23).

PMID: 39682194 PMC: 11640486. DOI: 10.3390/cancers16234008.


Association analysis of gut microbiota with LDL-C metabolism and microbial pathogenicity in colorectal cancer patients.

Qin M, Huang Z, Huang Y, Huang X, Chen C, Wu Y Lipids Health Dis. 2024; 23(1):367.

PMID: 39516755 PMC: 11546423. DOI: 10.1186/s12944-024-02333-4.


Alteration of ascending colon mucosal microbiota in patients after cholecystectomy.

Fan M, Jiang Q, Cui M, Zhao M, Wang J, Lu Y World J Gastrointest Surg. 2024; 16(8):2436-2450.

PMID: 39220062 PMC: 11362947. DOI: 10.4240/wjgs.v16.i8.2436.


References
1.
Saltzstein S, Behling C . Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213,383 cases from the California Cancer Registry. J Clin Gastroenterol. 2007; 41(2):173-7. DOI: 10.1097/01.mcg.0000225550.26751.6a. View

2.
Buscher J, Czernik D, Ewald J, Sauer U, Zamboni N . Cross-platform comparison of methods for quantitative metabolomics of primary metabolism. Anal Chem. 2009; 81(6):2135-43. DOI: 10.1021/ac8022857. View

3.
Dejea C, Wick E, Hechenbleikner E, White J, Welch J, Rossetti B . Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci U S A. 2014; 111(51):18321-6. PMC: 4280621. DOI: 10.1073/pnas.1406199111. View

4.
Nishino H, Murakosh M, Ii T, Takemura M, Kuchide M, Kanazawa M . Carotenoids in cancer chemoprevention. Cancer Metastasis Rev. 2003; 21(3-4):257-64. DOI: 10.1023/a:1021206826750. View

5.
Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View